Differences in EQ-5D scores for US and UK-based preference scoring systems in people with type 2 diabetes mellitus

被引：0
|
作者：
Sundaram, M.
Johnson, J. A.
Miller, L. A.
机构：
[1] W Virginia Univ, Sch Pharm, Morgantown, WV 26506 USA
[2] Inst Hlth Econ, Edmonton, AB, Canada
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68753-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A70 / A71
页数：2
相关论文
共 50 条
  • [41] ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE (HRQL) USING EQ-5D IN TYPE 2 DIABETES MELLITUS PATIENTS IN A UNIVERSITY TEACHING HOSPITAL
    Vohra, Y.
    Patidar, V
    Alexander, A.
    Nair, S.
    Thunga, G.
    Bhat, S.
    Acharya, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A616 - A616
  • [42] THE PSYCHOMETRIC PERFORMANCE OF THE EQ-5D, SF-6D AND DIABETES HEALTH PROFILE (DHP-18) IN TYPE 2 DIABETES
    Mulhern, B.
    Churchman, D.
    Meadows, K.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A504 - A504
  • [43] The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
    Brendan Mulhern
    Keith Meadows
    [J]. Health and Quality of Life Outcomes, 12
  • [44] The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
    Mulhern, Brendan
    Meadows, Keith
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [45] ANALYZING EQ-5D IN PHASE 3 CLINICAL TRIALS OF TYPE 2 DIABETES MELLITUS (T2DM): IS MEAN CHANGE CAPTURING PATIENT IMPACT?
    Slee, A.
    Traina, S.
    Neslusan, C.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A66 - A66
  • [46] QUALITY OF LIFE IN PATIENTS WITH TYPE 2 DIABETES IN POLAND: COMPARISON WITH GENERAL POPULATION USING EQ-5D QUESTIONNAIRE
    Golicki, D.
    Dudzinska, M.
    Zwolak, A.
    Tarach, J. S.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A445 - A445
  • [47] Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets
    Liv Ariane Augestad
    Kim Rand-Hendriksen
    Ivar Sønbø Kristiansen
    Knut Stavem
    [J]. PharmacoEconomics, 2012, 30 : 1203 - 1214
  • [48] Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets
    Augestad, Liv Ariane
    Rand-Hendriksen, Kim
    Kristiansen, Ivar Sonbo
    Stavem, Knut
    [J]. PHARMACOECONOMICS, 2012, 30 (12) : 1203 - 1214
  • [49] Quality of Life in Patients with Type 2 Diabetes in Poland - Comparison with the General Population Using the EQ-5D Questionnaire
    Golicki, Dominik
    Dudzinska, Marta
    Zwolak, Agnieszka
    Tarach, Jerzy S.
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 24 (01): : 139 - 146
  • [50] US and UK EQ-5D scoring algorithms result in different utility estimates: Results from an etanercept open-label extension trial in ankylosing spondylitis
    Maetzel, A.
    Boonen, A.
    Patel, V. D.
    Traina, S.
    Chiou, F.
    Tsuji, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 284 - 284
12345